Fusion Sleep Research Program

Fusion Sleep makes it a priority to participate in Sleep Medicine research. Our team has a lot to offer and plays a key role, both nationally and globally, by participating in projects, investigator initiated trials, and technology development.

We have created a clinical model that is unique and distinct from previous medical practice paradigms. Our research program is focused on patient-oriented advances in Sleep Medicine that result in disease prevention.

Focus on Disease Prevention

Fusion Sleep plays a key role, nationally and globally, by participating in research projects and technology development which will improve the field of Sleep Medicine.

This unique convergence of a medical practice, technology and research, has established the Company as a valuable partner in the discovery and development of new treatments.

Key Competencies

Diagnosis and Treatment of Restless Legs Syndrome

The Fusion Sleep team of Scientists & Clinicians are leaders researching the cause, diagnosis, and treatment pathways of Restless Legs Syndrome (RLS).

Based on the team’s scientific findings, systematic methods to accurately diagnose and treat the root cause of the disorder for many children and adults are now available. By choosing the appropriate treatment pathway for individuals suffering with RLS, the quality of life for patients and their families can be dramatically impacted.

The team envisions that this model will have a substantial socioeconomic impact through a more rational use of medical therapies, and the social, health and wealth fare benefits are affordable to affected individuals.

Fusion Sleep actively participates in research projects that involve RLS. Those projects are both focused on re-defining the basic diagnostic techniques applied, and on pharmaceutical trials, whereby new treatments are being tested.

Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

The Fusion Sleep team of Scientists & Clinicians is leading the way to a fundamentally new understanding of Attention Deficit Hyperactivity Disorder (ADHD), which will change our current approach to this common disorder.

Diagnosis and Treatment of Insomnia

Fusion Sleep regularly participates in clinical trials aimed at verifying pharmaceuticals with the indication to treat insomnia.

Clinical Outcomes Research

One of the cornerstones of the company’s research activities is its own outcomes research. The company seeks to track its own performance as it relates to therapy compliance and outcomes.

The therapy management component of the Fusion Sleep Clinic allows for comprehensive monitoring of treatment efficacy, whether it is for Continuous Positive Airway Treatment (CPAP), Bi-Level Therapy, Oral Appliance Therapy (OAT), or pharmacological interventions.

The rigorous follow-up with the Fusion Sleep clinicians and the respiratory therapists, in the Patient Support Center, enables a great deal of analysis on the success of various therapies. Physiological data, such as blood pressure, blood glucose levels in diabetics, and weight reduction, are also indicators to follow when looking at treatment effectiveness in certain patient populations.

It has been well documented that CPAP compliance has generally been suboptimal. Patients have a tendency to show initial acceptance to the therapy that gradually tapers off. Research has shown patient education to be of utmost importance when increasing CPAP compliance. A well-educated patient is a confident patient and will be more capable of dealing with any issues that may arise.

At every patient visit, all available information is downloaded from the devices and patients answer questionnaires regarding the effectiveness and success of the therapy. The Fusion Sleep staff keeps track of all data, including the CPAP therapy data and the other medical information obtained from the patient visit. Maintaining a high compliance and efficacy rate is a key component in performance tracking within Fusion Sleep. Additionally, by providing Oral Appliance Therapy (OAT) within the confinements of the Sleep Medicine Program, the possibility of providing therapy for patients with Sleep Disordered Breathing (SDB) is still maintained, even though CPAP therapy has been poorly tolerated.

Sleep Medicine Program of Excellence

Prestige Training Programs < Previous		Next > Experts in Pediatric Sleep Medicine